Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013))

Chao Feng Lin; Han Li Huang; Chieh Yu Peng; Yu Ching Lee; Hui Po Wang; Che Ming Teng; Shiow Lin Pan

doi:10.1016/j.taap.2019.114858

Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013))

Chao Feng Lin, Han Li Huang, Chieh Yu Peng, Yu Ching Lee, Hui Po Wang, Che Ming Teng, Shiow Lin Pan

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The authors regret that an incorrect description of the author's affiliation “a” has to be revised. The correct description of affiliation “a” is: Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica. The authors would like to apologise for any inconvenience caused.

Original language	English
Article number	114858
Journal	Toxicology and Applied Pharmacology
Volume	387
DOIs	https://doi.org/10.1016/j.taap.2019.114858
Publication status	Published - Jan 15 2020

ASJC Scopus subject areas

Toxicology
Pharmacology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.taap.2019.114858

Fingerprint

Dive into the research topics of 'Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013))'. Together they form a unique fingerprint.

Cite this

Lin, C. F., Huang, H. L., Peng, C. Y., Lee, Y. C., Wang, H. P., Teng, C. M., & Pan, S. L. (2020). Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013)). Toxicology and Applied Pharmacology, 387, Article 114858. https://doi.org/10.1016/j.taap.2019.114858

Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013)). / Lin, Chao Feng; Huang, Han Li; Peng, Chieh Yu et al.
In: Toxicology and Applied Pharmacology, Vol. 387, 114858, 15.01.2020.

Research output: Contribution to journal › Comment/debate › peer-review

Lin, CF, Huang, HL, Peng, CY, Lee, YC, Wang, HP, Teng, CM & Pan, SL 2020, 'Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013))', Toxicology and Applied Pharmacology, vol. 387, 114858. https://doi.org/10.1016/j.taap.2019.114858

Lin CF, Huang HL, Peng CY, Lee YC, Wang HP, Teng CM et al. Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013)). Toxicology and Applied Pharmacology. 2020 Jan 15;387:114858. doi: 10.1016/j.taap.2019.114858

Lin, Chao Feng ; Huang, Han Li ; Peng, Chieh Yu et al. / Corrigendum to : TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013)). In: Toxicology and Applied Pharmacology. 2020 ; Vol. 387.

@article{08e66a17666f410e9cbe365154fcc276,

title = "Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013))",

abstract = "The authors regret that an incorrect description of the author's affiliation “a” has to be revised. The correct description of affiliation “a” is: Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica. The authors would like to apologise for any inconvenience caused.",

author = "Lin, {Chao Feng} and Huang, {Han Li} and Peng, {Chieh Yu} and Lee, {Yu Ching} and Wang, {Hui Po} and Teng, {Che Ming} and Pan, {Shiow Lin}",

note = "Publisher Copyright: {\textcopyright} 2016 Elsevier Inc.",

year = "2020",

month = jan,

day = "15",

doi = "10.1016/j.taap.2019.114858",

language = "English",

volume = "387",

journal = "Toxicology and Applied Pharmacology",

issn = "0041-008X",

publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Corrigendum to

T2 - TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013))

AU - Lin, Chao Feng

AU - Huang, Han Li

AU - Peng, Chieh Yu

AU - Lee, Yu Ching

AU - Wang, Hui Po

AU - Teng, Che Ming

AU - Pan, Shiow Lin

PY - 2020/1/15

Y1 - 2020/1/15

N2 - The authors regret that an incorrect description of the author's affiliation “a” has to be revised. The correct description of affiliation “a” is: Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica. The authors would like to apologise for any inconvenience caused.

AB - The authors regret that an incorrect description of the author's affiliation “a” has to be revised. The correct description of affiliation “a” is: Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica. The authors would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85077731147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077731147&partnerID=8YFLogxK

U2 - 10.1016/j.taap.2019.114858

DO - 10.1016/j.taap.2019.114858

M3 - Comment/debate

C2 - 31843362

AN - SCOPUS:85077731147

SN - 0041-008X

VL - 387

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

M1 - 114858

ER -